We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected
About the Company The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in
Computational Chemistry / CADD (Level: Principal Scientist to Director)Full-timeAbout usRidgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years,
About us Ridgeline Discovery , a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years, Ridgeline has assembled an international team
The Institute of Molecular and Clinical Ophthalmology Basel (IOB) is seeking a highly motivated PostDoc to join the Quantitative Visual Physiology group. This role involves developing and leading projects related to vision physiology using experimental methods and
The Institute of Molecular and Clinical Ophthalmology Basel (IOB) seeks a highly motivated PostDoc. IOB is a research institute combining basic and clinical research. Its mission is to drive innovations in understanding vision and its diseases and
